PAVmed Inc
PAVM0.525USD
-0.000-0.06%
종가 08/04, 16:00（ET）시세는 15분 지연됩니다
8.81M시가총액
0.12P/E TTM
자세한 내용은 PAVmed Inc 회사
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is focused on enhanced personalized cancer care through remote patient monitoring using implantable vascular access port with wireless communication combined with an oncologist-designed remote digital healthcare platform.
회사 정보
종목 코드 PAVM
회사 이름PAVmed Inc
상장일Jul 27, 2016
CEODr. Lishan Aklog, M.D.
직원 수39
유형Ordinary Share
회계 연도 종료Jul 27
주소360 Madison Avenue
도시NEW YORK
증권 거래소NASDAQ Capital Market Consolidated
국가United States of America
우편 번호10017
전화12129494319
웹사이트https://pavmed.com/
종목 코드 PAVM
상장일Jul 27, 2016
CEODr. Lishan Aklog, M.D.
회사 임원
이름
이름/직위
직위
주식 보유
변동
Mr. Michael J. Glennon
Mr. Michael J. Glennon
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
81.67K
--
Dr. Lishan Aklog, M.D.
Dr. Lishan Aklog, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
78.72K
--
Mr. Ronald M. (Ron) Sparks
Mr. Ronald M. (Ron) Sparks
Independent Director
Independent Director
65.00K
--
Mr. Dennis M. Mcgrath
Mr. Dennis M. Mcgrath
President, Chief Financial Officer
President, Chief Financial Officer
50.83K
--
Mr. Sundeep Agrawal, M.D.
Mr. Sundeep Agrawal, M.D.
Director
Director
12.20K
--
Mr. Michael A. Gordon
Mr. Michael A. Gordon
General Counsel, Secretary
General Counsel, Secretary
--
--
Ms. Debra J. White
Ms. Debra J. White
Independent Director
Independent Director
--
--
Mr. Timothy (Tim) Baxter
Mr. Timothy (Tim) Baxter
Independent Director
Independent Director
--
--
Mr. Matt Riley
Mr. Matt Riley
Director of Investor Relations
Director of Investor Relations
--
--
Mr. Shaun M. O'Neil
Mr. Shaun M. O'Neil
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Michael J. Glennon
Mr. Michael J. Glennon
Independent Vice Chairman of the Board
Independent Vice Chairman of the Board
81.67K
--
Dr. Lishan Aklog, M.D.
Dr. Lishan Aklog, M.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
78.72K
--
Mr. Ronald M. (Ron) Sparks
Mr. Ronald M. (Ron) Sparks
Independent Director
Independent Director
65.00K
--
Mr. Dennis M. Mcgrath
Mr. Dennis M. Mcgrath
President, Chief Financial Officer
President, Chief Financial Officer
50.83K
--
Mr. Sundeep Agrawal, M.D.
Mr. Sundeep Agrawal, M.D.
Director
Director
12.20K
--
Mr. Michael A. Gordon
Mr. Michael A. Gordon
General Counsel, Secretary
General Counsel, Secretary
--
--
수익 분석
데이터 없음
데이터 없음
사업별
지역별
데이터 없음
주식 보유 통계
마지막 업데이트: Fri, May 16
마지막 업데이트: Fri, May 16
주주
주주 유형
주주
주주
비율
Tasso Partners, LLC
14.61%
First Manhattan Co. LLC
4.05%
Dubreville (Anthony Michael)
3.44%
Pavilion Venture Partners, L.L.C.
1.69%
Geode Capital Management, L.L.C.
0.53%
Other
75.68%
주주
주주
비율
Tasso Partners, LLC
14.61%
First Manhattan Co. LLC
4.05%
Dubreville (Anthony Michael)
3.44%
Pavilion Venture Partners, L.L.C.
1.69%
Geode Capital Management, L.L.C.
0.53%
Other
75.68%
주주 유형
주주
비율
Corporation
16.31%
Individual Investor
5.92%
Investment Advisor
5.88%
Investment Advisor/Hedge Fund
0.72%
Hedge Fund
0.19%
Research Firm
0.14%
Venture Capital
0.13%
Other
70.72%
기관 주식 보유
마지막 업데이트: Tue, Jul 1
마지막 업데이트: Tue, Jul 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q2
101
5.16M
29.28%
+2.77M
2025Q1
106
5.16M
31.74%
+3.03M
2024Q4
110
2.41M
17.67%
+156.53K
2024Q3
120
2.58M
24.42%
+197.13K
2024Q2
133
1.94M
20.61%
-301.78K
2024Q1
169
2.19M
26.52%
+433.78K
2023Q4
185
1.60M
20.86%
-48.73K
2023Q3
208
1.30M
18.00%
-268.87K
2023Q2
221
1.26M
18.65%
-731.24K
2023Q1
227
1.31M
20.36%
-649.18K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Tasso Partners, LLC
2.57M
14.61%
+2.57M
--
Feb 21, 2025
First Manhattan Co. LLC
714.10K
4.05%
+14.10K
+2.01%
Mar 31, 2025
Dubreville (Anthony Michael)
606.26K
3.44%
+606.26K
--
Aug 30, 2024
Pavilion Venture Partners, L.L.C.
297.11K
1.69%
--
--
Apr 22, 2025
Geode Capital Management, L.L.C.
92.67K
0.53%
+13.20K
+16.62%
Mar 31, 2025
Glennon (Michael J)
81.67K
0.46%
+1.00
+0.00%
Apr 22, 2025
The Vanguard Group, Inc.
81.49K
0.46%
--
--
Mar 31, 2025
Aklog (Lishan)
78.72K
0.45%
--
--
Apr 22, 2025
BlackRock Institutional Trust Company, N.A.
72.66K
0.41%
--
--
Mar 31, 2025
CAPTRUST Financial Advisors
65.05K
0.37%
+65.05K
--
Mar 31, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Aug 2
마지막 업데이트: Sat, Aug 2
이름
비율
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
유형
비율
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
날짜
유형
비율
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
Dec 04, 2023
Merger
15<1
